Date:2/9/2009

lood or tissue, and assays make these isolated molecules visible to facilitate such vital activities as biological research and detection of disease. QIAGEN has developed and markets more than 500 products as well as instruments that make their use more efficient and accurate. The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. QIAGEN's assay technologies include one of the broadest panels of molecular diagnostic tests available worldwide, including the only FDA-approved test for human papillomavirus (HPV), the primary cause of cervical cancer. QIAGEN employs more than 2,600 people in over 30 locations worldwide. Further information about QIAGEN can be found at www.qiagen.com.

'/>"/>

SOURCE QIAGEN Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related medicine news :

1. Olympic Gold Medal Swimmer Unveils Dental Health Education Campaign at Local Elementary School
2. Midbrook Installs New Cart Washer for Central Processing in Local Hospital
3. Local Business Leaders Assemble to Address Critical Issues Facing Los Angeles
4. Local Chiropractic Doctor Graduates from Elite Whiplash Trauma Training Program Led by International Scientific Authority, Dr. Arthur Croft
5. Local Infertility Specialist, Dr. Rachel Bennett, Westchester Reproductive Medicine, Opens New Office in Mount Kisco
6. Statement by UHW Trustee Eliseo Medina on the Trusteeship of Local UHW-W
7. As SEIU Prepares Hostile Takeover of United Healthcare Workers, Surveillance of Local Union Office Ends in Assault by Off-Duty Police Officer
8. Statewide Smoke-Free Law Must Be Comprehensive, Preserve Local Control and is Not a Substitute for a Significant Tobacco Tax Increase
9. Sandias microencapsulation project gives local entrepreneur warm glow
10. $5.15 Million Provided to Support Local Health Care Needs
11. Local Child Treated In Clinical Trial To Ease Symptoms of Cerebral Palsy